Product launches and Mellanox acquisition bode well, but we view shares as overvalued.
Although we expect to reduce our fair value estimate, we view shares as attractive and believe the company will survive as a downsized business.
We still believe the pandemic's long-term consequences will be limited for Target, as it should be held captive by an intensely competitive long-term pricing environment.
Our valuation and moat rating aren't affected by this company's decision.
Our long-term view of the wide-moat retailer remains in place, and we suggest investors await a more attractive entry point.
We made no change to our fair value estimate and see shares as undervalued.
We expect to reduce our fair value estimate but view shares as undervalued.
We are maintaining our fair value estimate and long-term outlook for the wide-moat essential business.
We're not expecting any changes to our fair value estimates for vaccine manufacturers, however, as most of the firms in our coverage with vaccine candidates have already stated that selling prices would be at a not-for-profit level.
Few surprises in filing, but sale of Goldman Sachs stake stands out in the first quarter.
We still think consolidation makes sense over the long term for the banking sector.
We are maintaining our fair value estimate and view shares as undervalued.
If an agreement is reached, the deal likely will face regulatory and antitrust barriers.
We are not making any changes to our fair value estimate or moat rating for BlackRock.
We expect to lower our fair value estimate for the no-moat company after a devastating first quarter.
Significant rides segment hits more than offset by growth in the firm's eats business.
We continue to view the wide-moat company as fairly valued, with the market appropriately appreciating the heavy patent losses over the next five years.
We also lowered our fair value estimates for these companies and see their competitive advantages waning from the impact of COVID-19.
Despite a major hit in the first quarter, we are not changing our fair value estimate for the no-moat firm.
We view shares of this narrow-moat firm as significantly undervalued.
We are maintaining our wide moat and our fair value estimate.
This wide-moat firm's annual meeting reminded us to take caution and preserve cash.
After a drop in earnings in the first quarter, we view this narrow-moat firm's shares as appealing.
We view this wide-moat firm as undervalued.
We are leaving our fair value estimate in place for the wide-moat company.
After a difficult first quarter and decline in revenue, we are maintaining our fair estimate for the no-moat firm.
Coronavirus-related investments change the wide-moat company's near-term margin profile, but also bolster network effect.
We are maintaining our fair value estimate for narrow-moat Apple, and we recommend prospective investors wait for a wider margin of safety.
No-moat-rated American Airlines reported a difficult first quarter as the COVID-19 pandemic has ground air traffic to a near-halt. We had previously priced in a very difficult 2020 and we are maintaining our $15.70 fair value estimate.
The wide-moat company saw only a partial effect from the COVID-19 crisis in the first quarter results.
Recovery for the wide-moat firm will be prolonged, but we view its dividend as one of the safest in the industry.
Despite the dividend cut, we are keeping our fair value estimate.
We are maintaining our fair value estimate for this no-moat firm.
We are raising our fair value estimate for this wide-moat firm after an impressive first quarter.
Nothing in GE’s first-quarter results alters our current long-term view of the firm.
Wide-moat Boeing reported a difficult first quarter as the firm weathers two concurrent challenges, but we’re maintaining our fair value estimate for the firm.
We are increasing our fair value estimate to $731 from $239. If a recession can’t stop Tesla then virtually nothing will, and we expect the company to remain a leader in autonomous technology and range.
We now recommend a wider margin of safety before allocating capital to this wide-moat name.
We don't think the Fed will be in any rush to raise rates, but so far its massive interventions appear to be working.
We're slightly raising our fair value estimate for the wide-moat firm.
We are maintaining our fair value estimate for this wide-moat firm despite the impact COVID-19 will have on the company's near-term growth.
We are maintaining our fair value estimate for this narrow-moat firm.
We see Starbucks as well positioned for market share gains ceded from smaller players.
Alphabet’s first-quarter results beat the FactSet consensus on revenue and EBIT, helped by strong ad spending in January and February, but followed by the pandemic-driven reversal in March.
Ford’s first-quarter results suffered hard from COVID-19 and the worst is yet to come.
We are reducing our fair value for Southwest Airlines as we incorporate a somewhat more bearish 2020 into our forecast.
We are making no changes to our fair value estimate for the wide-moat firm despite outflows and market losses from the first quarter.
We continue to view this wide-moat stock as undervalued and maintain our fair value estimate.
The wide-moat firm faces market headwinds, but we anticipate its outlook will reverse in 2021.
We are not changing our fair value estimate for this wide-moat firm after its first-quarter showed resilience and sustainable performance.